5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.49▼ | 0.48▼ | 0.48▲ | 0.48▲ | 0.46▲ |
MA10 | 0.49▼ | 0.48▲ | 0.48▲ | 0.46▲ | 0.49▲ |
MA20 | 0.48▲ | 0.48▲ | 0.48▲ | 0.44▲ | 0.55▼ |
MA50 | 0.48▲ | 0.48▲ | 0.47▲ | 0.50▲ | 0.74▼ |
MA100 | 0.48▲ | 0.46▲ | 0.45▲ | 0.55▼ | 0.98▼ |
MA200 | 0.48▲ | 0.44▲ | 0.45▲ | 0.71▼ | 1.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.000▲ | 0.000▲ | 0.013▲ | 0.004▲ |
RSI | 51.214▲ | 54.295▲ | 55.446▲ | 56.642▲ | 42.542▼ |
STOCH | 59.897 | 56.942 | 62.782 | 80.364▲ | 26.036 |
WILL %R | -58.586 | -34.524 | -24.370▲ | -5.455▲ | -63.903 |
CCI | -33.896 | 74.198 | 89.358 | 100.997▲ | -44.322 |
Friday, April 25, 2025 04:43 PM
1 Day LCTX -1.67% DJIA 0.05% Russell 2K 0.00% Health Care/Life Sciences -0.16% ...
|
Tuesday, April 22, 2025 05:00 AM
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana ...
|
Monday, April 21, 2025 05:00 PM
CARLSBAD, Calif., April 22, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.4954 | 0.504 | 0.47 | 0.504 | 479,416 |
30/04/25 | 0.47 | 0.499 | 0.47 | 0.499 | 1,488,505 |
29/04/25 | 0.4663 | 0.483 | 0.4663 | 0.4674 | 716,244 |
28/04/25 | 0.50 | 0.51 | 0.46 | 0.46 | 757,200 |
25/04/25 | 0.49 | 0.51 | 0.46 | 0.49 | 819,300 |
24/04/25 | 0.47 | 0.50 | 0.46 | 0.50 | 1,318,100 |
23/04/25 | 0.43 | 0.472 | 0.421 | 0.472 | 1,174,027 |
22/04/25 | 0.4083 | 0.4386 | 0.4037 | 0.4298 | 928,251 |
21/04/25 | 0.4157 | 0.4212 | 0.40 | 0.40 | 1,567,732 |
17/04/25 | 0.4147 | 0.439 | 0.4092 | 0.41 | 1,208,293 |
|
|
||||
|
|
||||
|
|